Selective Action of N-Arachidonoyl Dopamine on Viability and Proliferation of Stromal Cells from Eutopic and Ectopic Endometrium
N-arachidonoyl dopamine selectively reduced ectopic endometrial stromal cell viability via CB1 receptors and stimulated eutopic endometrial stromal cell proliferation via CB2 receptors.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
The study compared the cytotoxic effects of the endocannabinoid N-arachidonoyl dopamine (AA-DA) on cultured stromal cells derived from ectopic versus eutopic endometrium, focusing on concentration-dependent effects and receptor involvement. AA-DA at 1–20 μM was reported to more selectively reduce viability of ectopic endometrial stromal cells via interaction with cannabinoid type 1 receptors, while lower concentrations (<1 μM) increased proliferation of eutopic stromal cells and did not affect ectopic cell division through cannabinoid type 2 receptor interaction. A stated caveat is that these observations were generated in cultured cells rather than in vivo. This paper is centrally about endometriosis — it directly tests AA-DA selective effects on stromal cells from ectopic (endometriosis-associated) versus eutopic endometrium.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Full text
3,660 characters
· extracted from
oa-doi-fallback
· click to expand
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Condition tags
MeSH descriptors
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (2)
- The Pains of Endometriosis 2005
- Elevated Systemic Levels of Endocannabinoids and Related Mediators Across the Menstrual Cycle in Women With Endometriosis 2016
Cited by (2)
References (11)
- Elevated Systemic Levels of Endocannabinoids and Related Mediators Across the Menstrual Cycle in Women With Endometriosis via openalex
- The Pains of Endometriosis via openalex
- W2025435499 via openalex
- W2035898155 via openalex
- W2042027971 via openalex
- W2286791503 via openalex
- W2398332967 via openalex
- W2790303501 via openalex
- W1896798605 via openalex
- W4211081176 via openalex
- W1973232343 via openalex
Cited by (2)
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:22:48.502547+00:00